viernes, 3 de marzo de 2017

Journal of Hematology & Oncology | Home page

Journal of Hematology & Oncology | Home page

Biomed Central

Journal of Hematology & Oncology

JHO logo

Journal of Hematology & Oncology | Home page



Research highlights








Journal of Hematology & Oncology is now publishing Research Highlights, commentaries on recently published work that place the new research in the context of the current literature.

Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer
Janice Lu

AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy
Jingjing Wu, Jiaping Fu, Mingzhi Zhang, Delong Liu

Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting—its impact on clinical practice
Gaurav Goel, Weijing Sun

No hay comentarios:

Publicar un comentario